InfroFront Inc.
Basic information
- Head office
- 9F, A Building, 1-9-13 Nihonbashi Motomachi, Chuo-ku, Tokyo
- Chief executive
- Shin Kanaya
- Capital
- 30,000,000
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2001-04-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| アイジー・ホールディングス | ||||||||
| エムスリーグループ | ||||||||
| M3 Inc. | ||||||||
| IG-Holdings | ||||||||
| IMPEC Co., Ltd. | ||||||||
|
|
Network
History
Started supporting the editing and production of guidelines in the ophthalmology field. Supported 'Viral Conjunctivitis Guidelines (2003)', 'Contact Lens Practice Guidelines (2005)', 'Allergic Conjunctivitis Guidelines (2006)', and 'Infectious Keratitis Practice Guidelines (2007)'.![]()
Started supporting the editing and production of guidelines in the ophthalmology field. Supported "Viral Conjunctivitis Guidelines (2003)", "Contact Lens Practice Guidelines (2005)", "Allergic Conjunctivitis Guidelines (2006)", and "Infectious Keratitis Practice Guidelines (2007)".![]()
Started supporting the editing and production of guidelines in the field of ophthalmology. We are involved in supporting the guidelines 'Guidelines for Viral Conjunctivitis (2003)', 'Contact Lens Clinical Guidelines (2005)', 'Allergic Conjunctival Disease Guidelines (2006)', and 'Infectious Keratitis Clinical Guidelines (2007)'.![]()
Received the Nikkei Medical Award at the 10th Nikkei BP Advertising Awards. The winning entry was Takeda Pharmaceutical Company's international strategic product 'Brolipress' (antihypertensive drug).![]()
Received the "Nikkei Medical Award" at the 10th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)![]()
Received the 'Nikkei Medical Award' at the 10th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug).![]()
Received the Nikkei Medical Award for the second consecutive year at the 11th Nikkei BP Advertising Awards. The winning entry was Takeda Pharmaceutical Company's international strategic product 'Brolipress' (antihypertensive drug).![]()
Received the "Nikkei Medical Award" for the second consecutive year at the 11th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)![]()
Received the 'Nikkei Medical Award' for the second consecutive year at the 11th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug).![]()
Selected as 'Rising Company 2006' * by Teikoku Databank. * Emerging growing company selected by Teikoku Databank from companies whose most recent annual sales have increased by 100 million yen or more and sales have increased by 10% or more for the second consecutive term within 10 years of establishment, and whose corporate income has been announced within the second term. This represents about 1% of the 170,000 target companies.![]()
Selected as a 'Rising Company 2006' by Imperial Data Bank. * Companies founded or established within 10 years, with a recent annual sales of over 100 million yen and a consecutive 10% or greater revenue increase for two periods, and whose corporate taxable income was disclosed within two periods, were selected by Imperial Data Bank as emerging growth companies. About 1% of the approximately 170,000 target companies.![]()
Our website 'HeartFailure.com' was featured in the Nihon Keizai Shimbun 'Yū & eye' and NIKKEI NET 'Ikiki Health'.![]()
Our website "Heart Failure.com" was introduced in the Nihon Keizai Shimbun "Yu & eye" and NIKKEI NET "Ikiiki Kenko".![]()
Our website 'Heart Failure.com' was introduced in the Nihon Keizai Shimbun 'Yu & eye' and NIKKEI NET 'Ikiiki Kenko'.![]()
Received the Best Advertising Award at the 13th Nikkei BP Advertising Awards. The winning entry was Takeda Pharmaceutical Company's international strategic product 'Brolipress' (antihypertensive drug).![]()
Received "Nikkei BP Award Best Advertising Award" at the 13th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)![]()
Received 'Nikkei BP Award Best Advertising Award' at the 13th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug).![]()
Hosted a seminar titled 'Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States, and the Latest Marketing Trends'.![]()
Held our seminar "Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States and Latest Marketing Trends".![]()
Held our seminar 'Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States and Latest Marketing Trends'.![]()
Our President, Kondo Katsumi, delivered a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was 'Path to Innovative Pharmaceutical Promotion'.![]()
Katsumi Kondo, our President and CEO, gave a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was "The Road to Innovative Drug Promotion".![]()
Our representative director and president, Kondo Katsumi, gave a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was "The Path to Innovative Pharmaceutical Promotion".![]()
News
There is no news.
Public records
National Tax Agency basic information9010001073069
- Trade name
- 株式会社インフロント
- Trade name (kana)
- インフロント
- Name in English
- Corporation type
- 301
- Address
- 〒103-0023 東京都中央区日本橋本町1丁目9番13号
- Postal code
- 1030023
- Prefecture code
- 13
- City code
- 102
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2018-07-24
- Change date
- 2017-01-05
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 12
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 2463542
METI gBizINFO9010001073069
- Corporate number
- 9010001073069
- Trade name
- 株式会社インフロント
- Trade name (kana)
- インフロント
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都中央区日本橋本町1丁目9番13号
- Postal code
- 1030023
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 中央区
- City code
- 102
- Street address
- 日本橋本町1丁目9番13号
- Organisation type
- 301
- Processing type
- 12
- Correction type
- 1
- Status
- Representative
- 代表取締役 金谷 進
- Capital
- Employees
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- 2001-03-07
- Unified government qualification - grade
- ||C|
- Unified government qualification - business items
- 301|306
- Update date
- 2018-07-24
- Key information
- 9010001073069